Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
Clinical trial NCT00184002 · COMPLETED
Trial details
- NCT number
- NCT00184002
- Sponsor
- University of Southern California
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-10
- Primary completion
- 2012-12-19
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.